The effects of the degree of mobility reduction and prespecified risk factors on venous thromboembolism rates in acutely ill medical patients in the EXCLAIM study

被引:2
|
作者
Yusen, Roger D. [1 ]
Hull, Russell D. [2 ]
Schellong, Sebastian M. [3 ]
Tapson, Victor F. [4 ]
Monreal, Manuel [5 ]
Samama, Meyer-Michel [6 ]
Turpie, Alexander G. G. [7 ]
机构
[1] Washington Univ, St Louis, MO USA
[2] Univ Calgary, Foothills Hosp, Calgary, AB, Canada
[3] Hosp Carl Gustav Carus, Dresden, Germany
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Hosp German Trias Pujol, Barcelona, Spain
[6] Univ Hosp, Hotel Dieu, Paris, France
[7] McMaster Univ, HHSC McMaster Clin, Hamilton, ON, Canada
关键词
D O I
10.1182/blood.V110.11.1862.1862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1862
引用
收藏
页码:551A / 551A
页数:1
相关论文
共 50 条
  • [41] Prevalence of risk factors for venous thromboembolism in medical patients
    Fernandes, L. C.
    Rei, M. J.
    Duarte, A. M.
    Fernandez-Llimos, F.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 912 - 912
  • [42] Acquired risk factors for venous thromboembolism in medical patients
    Prandoni, Paolo
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2006, 35 (1-2) : 128 - 132
  • [43] RATES AND RISK FACTORS FOR VENOUS THROMBOEMBOLISM AMONG CRITICALLY ILL CHILDREN WITH TRACHEOSTOMY
    Havlicek, Elizabeth
    Palumbo, Jamie
    Soto-Campos, Gerardo
    Goldenberg, Neil
    Sochet, Anthony
    Morrison, John
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [44] A comparison of enoxoparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients.: Commentary
    Mahó, I
    PRESSE MEDICALE, 2000, 29 (06): : 308 - 309
  • [45] Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
    Alikhan, Raza
    Bedenis, Rachel
    Cohen, Alexander T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [46] Betrixaban A Novel Factor Xa Inhibitor for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
    Lee, Katie
    Cham, Samantha
    Lam, Sum
    CARDIOLOGY IN REVIEW, 2018, 26 (06) : 331 - 338
  • [47] Rationalization of risk factors for venous thromboembolism in medical in-patients: a prospective study
    Pottier, P
    Planchon, B
    Truchaud, F
    Pistorius, MA
    Furic, I
    Grolleau, JY
    JOURNAL DES MALADIES VASCULAIRES, 2000, 25 (04) : 241 - 249
  • [48] Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals
    Martin, Anne-Celine
    Huang, Wei
    Goldhaber, Samuel Z.
    Hull, Russell D.
    Hernandez, Adrian F.
    Gibson, Charles-Michael
    Anderson, Frederick A.
    Cohen, Alexander T.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [49] Venous Thromboembolism in Critically Ill Medical Patients Receiving Chemoprophylaxis: A Focus on Obesity and Other Risk Factors
    Fontaine, Gabriel V.
    Vigil, Emily
    Wohlt, Paul D.
    Lloyd, James F.
    Evans, R. Scott
    Collingridge, David S.
    Stevens, Scott M.
    Woller, Scott C.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (03) : 265 - 273
  • [50] Use of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Venous Thromboembolism Risk Model and Elevated D-Dimer to Identify a High Venous Thromboembolism Risk in an Acutely Ill Medical Population for Extended Thromboprophylaxis
    Spyropoulos, Alex C.
    Raskob, Gary
    Spiro, Theodore
    De Sanctis, Yoriko
    Xu, Jianfeng
    Peluso, Colleen
    Barnathan, Elliot S.
    CIRCULATION, 2019, 140